|
⚲
|
| Keyboard |
| Taro Inaba | |
|---|---|
| Firm | |
| Address | c/o Capacity Bio, Inc 3175 Hanover St Palo Alto, CA 94304 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Capacity Bio Inc | 021-470977 | Director | 19.2 M of 35.3 M |
||
| IMEL Biotherapeutics Inc | 021-421205 | Director | 15.0 M of 20.0 M |
||
| Napajen Pharma Inc | 021-413786 | Director | 0.5 M of 2.0 M |
||
| Edison Pharmaceuticals Inc | 021-214377 | Director | 50.0 M of 100.0 M |
||
| Boston Biomedical Inc | 021-143515 | Director | 2.0 M of 2.0 M |
||
| Remiges Ventures Inc | |||||
| Remiges Biopharma Fund II LP | 021-342260 | Director | of 150.0 M |
95.0 M | |
| Remiges Biopharma Fund LP | 021-218532 | Director | 80.0 M of 80.0 M |
80.0 M | |